
2023 Diabetes Update: Cases for Clinical Decision-Making

2023 Diabetes Update: Cases for Clinical Decision-Making is organized by Connect Educate Impact (CEI).
Initial Release Date: March 1, 2023
Planned Expiration Date: March 1, 2026
Description:
Four cases on the most recent diabetes standards of care updates are discussed in this course, including semaglutide dosing, and treating diabetes with associated ASCVD and heart failure. Connect your learning to practice with these quick 15-minute cases for a total of one hour of CE.
Upon successful completion of this application-based CPE course, pharmacists should be able to:
• Utilize a specific patient's medical history, medications, laboratory results, and adherence matters to optimize diabetes therapy.
• Apply the 2023 Diabetes guidelines to a patient with diabetes and ASCVD.
• Apply the 2023 Diabetes guidelines to a patient with diabetes and heart failure.
• Recommend type 2 diabetes treatment using the 2023 ADA pharmacologic approach.
Additional details will be posted as soon as information is available.